RMD
RESMED INC
NYSE · Healthcare · Medical - Instruments & Supplies · US
$229.94
+3.12%Price chart
Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15
Key dataSep 15, 2026
Open$226.36
From 52W high−18.83%
Volume345216.00
Market cap$33.17B
P/E (TTM)22.0x
P/S (TTM)5.9x
Div yield1.07%
Key dataSep 15, 2026
Open
$226.36
From 52W high
−18.83%
Volume
345216.00
Market cap
$33.17B
ValuationView details →
P/E (Fwd)
19.0x
EV/EBITDA
15.2x
P/E (TTM)
22.0x
RSI (14)
48.8
MomentumView details →
1D Return
+3.12%
YTD Return
−7.36%
SummaryUpdated Jun 1, 2026
ResMed Inc. (NYSE:RMD) is a medical device company founded in 1989 and headquartered in San Diego, California. The company went public in 1995 and has evolved from a sleep apnea device manufacturer into a comprehensive digital health platform serving patients with sleep-disordered breathing and other respiratory conditions. ResMed operates globally across approximately 140 countries, developing cloud-connected medical devices and software solutions that serve both patients in their homes and healthcare providers managing out-of-hospital care.
Similar companies
Latest newsMore news →
Resmed director, chairman and CEO Michael J. Farrell sold 4,991 shares for $1,110,191 on September 8, 2026, according to a Form 4 filed with the SEC.5d agoResMed shares fell about 6% in morning trading on Friday after the company issued a weak fiscal 2027 revenue forecast.39d agoResMed reported Q2 CY2026 revenue of $1.46 billion, up 8.6% year on year, in line with analyst estimates, and adjusted EPS of $2.95, beating consensus by 2%.40d ago